> INVENTAGES is one of the world's largest life-sciences, nutrition and wellness focused venture capital funds, investing in the best companies around the world. With US$ 1.5 billion under management, and offices in Geneva, Nassau, and Auckland, we have the resources to provide continued support to growing companies.

www.inventages.com

> BIOAM is a Venture capital fund of 51 million euros. Its main dormant partners are CDC PME and AXA PRIVATE EQUITY. BIOAM invests in the initial funding of biotechnology companies with high growth potential, from French public or private research.

www.bioam.fr

> SGAM AI is a 100 % subsidiary of Société Générale Asset Management, with 47.4 billion euros under their management at 31st December 2006 and 340 employees world wide. Taking advantage of the strategic and financial commitment of the Groupe Société Générale, SGAM Alternative Investments has become a leader in the global alternative management sector.

www.sgam-ai.com

> INNOVERIS - Viveris Management participates in the key segments of investment capital (venture capital, development capital and LBOs). More than half of its managed funds, 190 M€, are dedicated to technological venture capital within the framework of seven high tech mutual funds in the INNOVERIS range (I to VII).

www.viverismanagement.com